{"transactions":[{"id":744659,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T21:42:05.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting."}],"balance_after":13000,"derivative":{"exercise_price":51.84,"expiration_date":"2036-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001193125-26-264286","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526264286/ownership.xml","form_type":"4"}},{"id":976291,"issuer":{"id":4763,"kind":"organization","name":"Vor Biopharma Inc.","symbol":"VOR"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-09T13:00:10.000Z","date":"2025-12-05","kind":"grant","planned":false,"acquired":true,"shares":1388274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price per share of common stock subject to the option will be (a) $17.80 per share, or (b) to the extent the option is exercised following the end of the Retention Period, $8.18 per share, the closing price of a share of common stock on the grant date (December 5, 2025). The \"Retention Period\" begins on December 5, 2025 and ends on the earlier of (i) December 5, 2027 or (ii) a Change in Control (as defined in the 2021 Plan) during the Reporting Person's Continuous Service (as defined in the 2021 Plan) with the Issuer. In the event that the Reporting Person's Continuous Service terminates for any reason or no reason prior to the end of the Retention Period, the exercise price per share of Common Stock subject to the Option will be as set forth in clause (a) above."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares underlying the option vest on July 1, 2026, with the remainder vesting in equal monthly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date."}],"balance_after":1388274,"derivative":{"exercise_price":17.8,"expiration_date":"2035-12-04","underlying":"Common Stock","underlying_shares":1388274},"source":{"system":"sec-edgar","filing":"0001511034-25-000006","document":"form4-12092025_081205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817229/000151103425000006/form4-12092025_081205.xml","form_type":"4"}},{"id":976290,"issuer":{"id":4763,"kind":"organization","name":"Vor Biopharma Inc.","symbol":"VOR"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-12-09T13:00:10.000Z","date":"2025-12-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":694137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 18, 2025, the Issuer effected a 1-for-20 reverse stock split. The share counts herein reflect the reverse stock split."},{"field":"shares","element":"transactionShares","label":"F2","text":"On December 5, 2025, the Issuer's Compensation Committee of the Board of Directors approved the cancellation of the previously awarded grant of 694,137 restricted stock units, which was reported in a Form 4 filed on July 10, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001511034-25-000006","document":"form4-12092025_081205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817229/000151103425000006/form4-12092025_081205.xml","form_type":"4"}},{"id":1089429,"issuer":{"id":4763,"kind":"organization","name":"Vor Biopharma Inc.","symbol":"VOR"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-07-10T20:51:30.000Z","date":"2025-07-09","kind":"grant","planned":false,"acquired":true,"shares":13882750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. 1/4th of the RSUs vest on July 1, 2026, with the remainder vesting in equal quarterly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date."}],"balance_after":13882750,"source":{"system":"sec-edgar","filing":"0001415889-25-019640","document":"form4-07102025_080725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817229/000141588925019640/form4-07102025_080725.xml","form_type":"4"}},{"id":1119664,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T21:30:13.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders."}],"balance_after":13000,"derivative":{"exercise_price":38.57,"expiration_date":"2035-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0000950170-25-083269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025083269/ownership.xml","form_type":"4"}},{"id":1496687,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-31T20:15:06.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on May 31, 2024; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2025 Annual General Meeting of Shareholders."}],"balance_after":13000,"derivative":{"exercise_price":54.06,"expiration_date":"2034-05-30","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0000950170-24-067329","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024067329/ownership.xml","form_type":"4"}},{"id":2237352,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2022-06-10T01:18:44.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":43000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2022, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":43000,"derivative":{"exercise_price":0.73,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":43000},"source":{"system":"sec-edgar","filing":"0001209191-22-035687","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511034/000120919122035687/doc4.xml","form_type":"4"}},{"id":2675147,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2021-06-09T21:26:09.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2021, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":6.8,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-039231","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511034/000120919121039231/doc4.xml","form_type":"4"}},{"id":3085924,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2020-07-10T00:00:22.000Z","date":"2020-07-08","kind":"exercise","acquired":false,"shares":1203,"price":32.63,"value":39253.89,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":32.63,"exercise_date":"2018-03-10","expiration_date":"2027-03-10","underlying":"Common Stock","underlying_shares":1203},"source":{"system":"sec-edgar","filing":"0001209191-20-042060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120042060/doc4.xml","form_type":"4"}},{"id":3085923,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2020-07-10T00:00:22.000Z","date":"2020-07-08","kind":"exercise","acquired":false,"shares":218,"price":13.71,"value":2988.78,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":218},"source":{"system":"sec-edgar","filing":"0001209191-20-042060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120042060/doc4.xml","form_type":"4"}},{"id":3085922,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2020-07-10T00:00:22.000Z","date":"2020-07-08","kind":"exercise","acquired":false,"shares":2385,"price":13.71,"value":32698.35,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":2385},"source":{"system":"sec-edgar","filing":"0001209191-20-042060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120042060/doc4.xml","form_type":"4"}},{"id":3085921,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2020-07-10T00:00:22.000Z","date":"2020-07-08","kind":"exercise","acquired":true,"shares":1203,"price":32.63,"value":39253.89,"ownership":{"direct":true},"balance_after":20260,"source":{"system":"sec-edgar","filing":"0001209191-20-042060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120042060/doc4.xml","form_type":"4"}},{"id":3085920,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2020-07-10T00:00:22.000Z","date":"2020-07-08","kind":"exercise","acquired":true,"shares":218,"price":13.71,"value":2988.78,"ownership":{"direct":true},"balance_after":19057,"source":{"system":"sec-edgar","filing":"0001209191-20-042060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120042060/doc4.xml","form_type":"4"}},{"id":3085919,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2020-07-10T00:00:22.000Z","date":"2020-07-08","kind":"exercise","acquired":true,"shares":2385,"price":13.71,"value":32698.35,"ownership":{"direct":true},"balance_after":18839,"source":{"system":"sec-edgar","filing":"0001209191-20-042060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120042060/doc4.xml","form_type":"4"}},{"id":3085918,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2020-07-10T00:00:22.000Z","date":"2020-05-11","kind":"gift","acquired":false,"shares":20425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of shares of common stock by the reporting person to family trusts."}],"balance_after":16454,"source":{"system":"sec-edgar","filing":"0001209191-20-042060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120042060/doc4.xml","form_type":"4"}},{"id":3111658,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-06-12T16:17:55.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":7000,"derivative":{"exercise_price":11.88,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-20-036257","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919120036257/doc4.xml","form_type":"4"}},{"id":3111657,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T16:17:55.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan."}],"balance_after":4500,"source":{"system":"sec-edgar","filing":"0001209191-20-036257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919120036257/doc4.xml","form_type":"4"}},{"id":3114385,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2020-06-10T20:28:28.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":28100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2020 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":28100,"derivative":{"exercise_price":8.89,"expiration_date":"2030-06-07","underlying":"Common Stock","underlying_shares":28100},"source":{"system":"sec-edgar","filing":"0001209191-20-035519","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511034/000120919120035519/doc4.xml","form_type":"4"}},{"id":3242217,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2020-02-29T01:00:32.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant."}],"balance_after":37500,"derivative":{"exercise_price":114.47,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-20-014223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014223/doc4.xml","form_type":"4"}},{"id":3242216,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2020-02-29T01:00:32.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":6700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest and become exercisable on the first anniversary of the grant date, and additional 25% will vest and become exercisable on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested and exercisable on the fourth anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest and become exercisable on the first anniversary of the grant date, and additional 25% will vest and become exercisable on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested and exercisable on the fourth anniversary of the grant date."}],"balance_after":36879,"source":{"system":"sec-edgar","filing":"0001209191-20-014223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014223/doc4.xml","form_type":"4"}},{"id":3339866,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2019-12-18T01:00:24.000Z","date":"2019-12-13","kind":"exercise","acquired":false,"shares":14723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":39277,"derivative":{"exercise_price":34.92,"exercise_date":"2014-06-04","expiration_date":"2023-06-04","underlying":"Common Stock","underlying_shares":14723},"source":{"system":"sec-edgar","filing":"0001209191-19-061048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061048/doc4.xml","form_type":"4"}},{"id":3339865,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2019-12-18T01:00:24.000Z","date":"2019-12-13","kind":"exercise","acquired":false,"shares":21875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":10874,"derivative":{"exercise_price":32.63,"exercise_date":"2018-03-10","expiration_date":"2027-03-10","underlying":"Common Stock","underlying_shares":21875},"source":{"system":"sec-edgar","filing":"0001209191-19-061048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061048/doc4.xml","form_type":"4"}},{"id":3339864,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2019-12-18T01:00:24.000Z","date":"2019-12-13","kind":"exercise","acquired":false,"shares":69479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":0,"derivative":{"exercise_price":29.03,"exercise_date":"2015-02-28","expiration_date":"2024-02-28","underlying":"Common Stock","underlying_shares":69479},"source":{"system":"sec-edgar","filing":"0001209191-19-061048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061048/doc4.xml","form_type":"4"}},{"id":3339863,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2019-12-18T01:00:24.000Z","date":"2019-12-13","kind":"exercise","acquired":false,"shares":10466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":0,"derivative":{"exercise_price":23.85,"exercise_date":"2013-11-05","expiration_date":"2022-11-05","underlying":"Common Stock","underlying_shares":10466},"source":{"system":"sec-edgar","filing":"0001209191-19-061048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061048/doc4.xml","form_type":"4"}},{"id":3339862,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2019-12-18T01:00:24.000Z","date":"2019-12-13","kind":"exercise","acquired":false,"shares":4138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":2633,"derivative":{"exercise_price":13.71,"exercise_date":"2016-09-09","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":4138},"source":{"system":"sec-edgar","filing":"0001209191-19-061048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061048/doc4.xml","form_type":"4"}},{"id":3339861,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2019-12-18T01:00:24.000Z","date":"2019-12-13","kind":"exercise","acquired":false,"shares":4319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":3085,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":4319},"source":{"system":"sec-edgar","filing":"0001209191-19-061048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061048/doc4.xml","form_type":"4"}},{"id":3339860,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-12-18T01:00:24.000Z","date":"2019-12-13","kind":"sale","acquired":false,"shares":125000,"price":125.5,"value":15687500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":30179,"source":{"system":"sec-edgar","filing":"0001209191-19-061048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061048/doc4.xml","form_type":"4"}},{"id":3339859,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-12-18T01:00:24.000Z","date":"2019-12-13","kind":"exercise","acquired":true,"shares":14723,"price":34.92,"value":514127.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":155179,"source":{"system":"sec-edgar","filing":"0001209191-19-061048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061048/doc4.xml","form_type":"4"}},{"id":3339858,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-12-18T01:00:24.000Z","date":"2019-12-13","kind":"exercise","acquired":true,"shares":21875,"price":32.63,"value":713781.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":140456,"source":{"system":"sec-edgar","filing":"0001209191-19-061048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061048/doc4.xml","form_type":"4"}},{"id":3339857,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-12-18T01:00:24.000Z","date":"2019-12-13","kind":"exercise","acquired":true,"shares":69479,"price":29.03,"value":2016975.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":118581,"source":{"system":"sec-edgar","filing":"0001209191-19-061048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061048/doc4.xml","form_type":"4"}},{"id":3339856,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-12-18T01:00:24.000Z","date":"2019-12-13","kind":"exercise","acquired":true,"shares":10466,"price":23.85,"value":249614.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":49102,"source":{"system":"sec-edgar","filing":"0001209191-19-061048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061048/doc4.xml","form_type":"4"}},{"id":3339855,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-12-18T01:00:24.000Z","date":"2019-12-13","kind":"exercise","acquired":true,"shares":4138,"price":13.71,"value":56731.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":38636,"source":{"system":"sec-edgar","filing":"0001209191-19-061048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061048/doc4.xml","form_type":"4"}},{"id":3339854,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-12-18T01:00:24.000Z","date":"2019-12-13","kind":"exercise","acquired":true,"shares":4319,"price":13.71,"value":59213.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":34498,"source":{"system":"sec-edgar","filing":"0001209191-19-061048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119061048/doc4.xml","form_type":"4"}},{"id":3431525,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock Appreciation Right","published_at":"2019-08-22T23:20:04.000Z","date":"2019-08-21","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved the exercise of a stock appreciation right (\"SAR\") relating to 100,000 shares of common stock, upon which the reporting person received shares of common stock net of shares of common stock withheld as payment of the exercise price and withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the SAR vested on the first anniversary measured from November 5, 2012 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vested in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the SAR were fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":0,"derivative":{"exercise_price":23.85,"expiration_date":"2022-11-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-047178","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119047178/doc4.xml","form_type":"4"}},{"id":3431524,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-08-22T23:20:04.000Z","date":"2019-08-22","kind":"gift","acquired":false,"shares":42535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved a gift of shares of common stock by the reporting person to a family trust."}],"balance_after":30179,"source":{"system":"sec-edgar","filing":"0001209191-19-047178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119047178/doc4.xml","form_type":"4"}},{"id":3431523,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-08-22T23:20:04.000Z","date":"2019-08-21","kind":"tax_withholding","acquired":false,"shares":57465,"price":101.5,"value":5832697.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved the exercise of a stock appreciation right (\"SAR\") relating to 100,000 shares of common stock, upon which the reporting person received shares of common stock net of shares of common stock withheld as payment of the exercise price and withholding taxes."}],"balance_after":72714,"source":{"system":"sec-edgar","filing":"0001209191-19-047178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119047178/doc4.xml","form_type":"4"}},{"id":3431522,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-08-22T23:20:04.000Z","date":"2019-08-21","kind":"exercise","acquired":true,"shares":100000,"price":23.85,"value":2385000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved the exercise of a stock appreciation right (\"SAR\") relating to 100,000 shares of common stock, upon which the reporting person received shares of common stock net of shares of common stock withheld as payment of the exercise price and withholding taxes."}],"balance_after":130179,"source":{"system":"sec-edgar","filing":"0001209191-19-047178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119047178/doc4.xml","form_type":"4"}},{"id":3438018,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2019-08-15T20:33:47.000Z","date":"2019-08-15","kind":"exercise","acquired":false,"shares":260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person executed a cash exercise of options without a subsequent sale of the underlying common stock."}],"balance_after":218,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":260},"source":{"system":"sec-edgar","filing":"0001209191-19-046150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119046150/doc4.xml","form_type":"4"}},{"id":3438017,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2019-08-15T20:33:47.000Z","date":"2019-08-15","kind":"exercise","acquired":false,"shares":985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person executed a cash exercise of options without a subsequent sale of the underlying common stock."}],"balance_after":2385,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":985},"source":{"system":"sec-edgar","filing":"0001209191-19-046150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119046150/doc4.xml","form_type":"4"}},{"id":3438016,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2019-08-15T20:33:47.000Z","date":"2019-08-15","kind":"exercise","acquired":false,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person executed a cash exercise of options without a subsequent sale of the underlying common stock."}],"balance_after":0,"derivative":{"exercise_price":13.9,"exercise_date":"2016-02-27","expiration_date":"2025-02-27","underlying":"Common Stock","underlying_shares":2625},"source":{"system":"sec-edgar","filing":"0001209191-19-046150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119046150/doc4.xml","form_type":"4"}},{"id":3438015,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2019-08-15T20:33:47.000Z","date":"2019-08-15","kind":"exercise","acquired":false,"shares":3021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person executed a cash exercise of options without a subsequent sale of the underlying common stock."}],"balance_after":0,"derivative":{"exercise_price":29.03,"exercise_date":"2015-02-28","expiration_date":"2024-02-28","underlying":"Common Stock","underlying_shares":3021},"source":{"system":"sec-edgar","filing":"0001209191-19-046150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119046150/doc4.xml","form_type":"4"}},{"id":3438014,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2019-08-15T20:33:47.000Z","date":"2019-08-15","kind":"exercise","acquired":false,"shares":2863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person executed a cash exercise of options without a subsequent sale of the underlying common stock."}],"balance_after":0,"derivative":{"exercise_price":34.92,"exercise_date":"2014-06-04","expiration_date":"2023-06-04","underlying":"Common Stock","underlying_shares":2863},"source":{"system":"sec-edgar","filing":"0001209191-19-046150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119046150/doc4.xml","form_type":"4"}},{"id":3438013,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-08-15T20:33:47.000Z","date":"2019-08-15","kind":"exercise","acquired":true,"shares":260,"price":13.71,"value":3564.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person executed a cash exercise of options without a subsequent sale of the underlying common stock."}],"balance_after":30179,"source":{"system":"sec-edgar","filing":"0001209191-19-046150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119046150/doc4.xml","form_type":"4"}},{"id":3438012,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-08-15T20:33:47.000Z","date":"2019-08-15","kind":"exercise","acquired":true,"shares":985,"price":13.71,"value":13504.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person executed a cash exercise of options without a subsequent sale of the underlying common stock."}],"balance_after":29919,"source":{"system":"sec-edgar","filing":"0001209191-19-046150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119046150/doc4.xml","form_type":"4"}},{"id":3438011,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-08-15T20:33:47.000Z","date":"2019-08-15","kind":"exercise","acquired":true,"shares":2625,"price":13.9,"value":36487.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person executed a cash exercise of options without a subsequent sale of the underlying common stock."}],"balance_after":28934,"source":{"system":"sec-edgar","filing":"0001209191-19-046150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119046150/doc4.xml","form_type":"4"}},{"id":3438010,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-08-15T20:33:47.000Z","date":"2019-08-15","kind":"exercise","acquired":true,"shares":3021,"price":29.03,"value":87699.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person executed a cash exercise of options without a subsequent sale of the underlying common stock."}],"balance_after":26309,"source":{"system":"sec-edgar","filing":"0001209191-19-046150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119046150/doc4.xml","form_type":"4"}},{"id":3438009,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-08-15T20:33:47.000Z","date":"2019-08-15","kind":"exercise","acquired":true,"shares":2863,"price":34.92,"value":99975.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person executed a cash exercise of options without a subsequent sale of the underlying common stock."}],"balance_after":23288,"source":{"system":"sec-edgar","filing":"0001209191-19-046150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119046150/doc4.xml","form_type":"4"}},{"id":3481222,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-06-21T16:10:20.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":12500,"derivative":{"exercise_price":11.74,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-19-038459","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919119038459/doc4.xml","form_type":"4"}},{"id":3496777,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-06-07T20:50:38.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":12400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2019 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":12400,"derivative":{"exercise_price":6.33,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":12400},"source":{"system":"sec-edgar","filing":"0001567619-19-013072","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511034/000156761919013072/doc1.xml","form_type":"4"}},{"id":3574431,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-03-30T00:01:28.000Z","date":"2019-03-28","kind":"tax_withholding","acquired":false,"shares":2953,"price":118.68,"value":350462.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of performance-based restricted stock units."}],"balance_after":20425,"source":{"system":"sec-edgar","filing":"0001209191-19-021878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119021878/doc4.xml","form_type":"4"}},{"id":3574430,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-03-30T00:01:28.000Z","date":"2019-03-28","kind":"grant","acquired":true,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reflects the vesting of previously granted performance-based restricted stock units."}],"balance_after":23378,"source":{"system":"sec-edgar","filing":"0001209191-19-021878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119021878/doc4.xml","form_type":"4"}},{"id":3585191,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2019-03-21T00:00:17.000Z","date":"2019-03-19","kind":"exercise","acquired":false,"shares":43,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":478,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":43},"source":{"system":"sec-edgar","filing":"0001209191-19-020686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119020686/doc4.xml","form_type":"4"}},{"id":3585190,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2019-03-21T00:00:17.000Z","date":"2019-03-19","kind":"exercise","acquired":false,"shares":164,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3370,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":164},"source":{"system":"sec-edgar","filing":"0001209191-19-020686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119020686/doc4.xml","form_type":"4"}},{"id":3585189,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2019-03-21T00:00:17.000Z","date":"2019-03-19","kind":"exercise","acquired":false,"shares":3511,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2625,"derivative":{"exercise_price":13.9,"exercise_date":"2016-02-27","expiration_date":"2025-02-27","underlying":"Common Stock","underlying_shares":3511},"source":{"system":"sec-edgar","filing":"0001209191-19-020686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119020686/doc4.xml","form_type":"4"}},{"id":3585188,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2019-03-21T00:00:17.000Z","date":"2019-03-19","kind":"exercise","acquired":false,"shares":11768,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":23.85,"exercise_date":"2013-11-05","expiration_date":"2022-11-05","underlying":"Common Stock","underlying_shares":11768},"source":{"system":"sec-edgar","filing":"0001209191-19-020686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119020686/doc4.xml","form_type":"4"}},{"id":3585187,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-03-21T00:00:17.000Z","date":"2019-03-19","kind":"tax_withholding","acquired":false,"shares":2625,"price":126.47,"value":331983.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock owned by the reporting person that were delivered to the Company to pay the aggregate exercise price with respect to the option exercises reported on this Form 4 filing. Such an \"option swap\" enables the exercise and holding of shares of Common Stock by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock owned by the reporting person that were delivered to the Company to pay the aggregate exercise price with respect to the option exercises reported on this Form 4 filing. Such an \"option swap\" enables the exercise and holding of shares of Common Stock by the reporting person."}],"balance_after":16729,"source":{"system":"sec-edgar","filing":"0001209191-19-020686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119020686/doc4.xml","form_type":"4"}},{"id":3585186,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-03-21T00:00:17.000Z","date":"2019-03-19","kind":"exercise","acquired":true,"shares":43,"price":13.71,"value":589.53,"ownership":{"direct":true},"balance_after":19354,"source":{"system":"sec-edgar","filing":"0001209191-19-020686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119020686/doc4.xml","form_type":"4"}},{"id":3585185,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-03-21T00:00:17.000Z","date":"2019-03-19","kind":"exercise","acquired":true,"shares":164,"price":13.71,"value":2248.44,"ownership":{"direct":true},"balance_after":19311,"source":{"system":"sec-edgar","filing":"0001209191-19-020686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119020686/doc4.xml","form_type":"4"}},{"id":3585184,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-03-21T00:00:17.000Z","date":"2019-03-19","kind":"exercise","acquired":true,"shares":3511,"price":13.9,"value":48802.9,"ownership":{"direct":true},"balance_after":19147,"source":{"system":"sec-edgar","filing":"0001209191-19-020686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119020686/doc4.xml","form_type":"4"}},{"id":3585183,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-03-21T00:00:17.000Z","date":"2019-03-19","kind":"exercise","acquired":true,"shares":11768,"price":23.85,"value":280666.8,"ownership":{"direct":true},"balance_after":15636,"source":{"system":"sec-edgar","filing":"0001209191-19-020686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119020686/doc4.xml","form_type":"4"}},{"id":3620942,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2019-03-05T01:08:50.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant."}],"balance_after":55000,"derivative":{"exercise_price":145.48,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-19-016041","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119016041/doc4.xml","form_type":"4"}},{"id":3620941,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-03-05T01:08:50.000Z","date":"2019-02-28","kind":"disposition_to_issuer","acquired":false,"shares":4781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Forfeiture of 4,781 shares of restricted stock due to performance goal not met."}],"balance_after":3868,"source":{"system":"sec-edgar","filing":"0001209191-19-016041","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119016041/doc4.xml","form_type":"4"}},{"id":3669253,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-09T01:02:41.000Z","date":"2019-02-07","kind":"exercise","acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on October 29, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":10466,"derivative":{"exercise_price":23.85,"exercise_date":"2013-11-05","expiration_date":"2022-11-05","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-19-008776","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119008776/doc4.xml","form_type":"4"}},{"id":3669252,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-02-09T01:02:41.000Z","date":"2019-02-07","kind":"sale","acquired":false,"shares":65000,"price":145,"value":9425000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on October 29, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":8649,"source":{"system":"sec-edgar","filing":"0001209191-19-008776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119008776/doc4.xml","form_type":"4"}},{"id":3669251,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-02-09T01:02:41.000Z","date":"2019-02-07","kind":"exercise","acquired":true,"shares":65000,"price":23.85,"value":1550250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on October 29, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":73649,"source":{"system":"sec-edgar","filing":"0001209191-19-008776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119008776/doc4.xml","form_type":"4"}},{"id":3680381,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-02T01:24:12.000Z","date":"2019-01-31","kind":"exercise","acquired":false,"shares":21198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":75466,"derivative":{"exercise_price":23.85,"exercise_date":"2013-11-05","expiration_date":"2022-11-05","underlying":"Common Stock","underlying_shares":21198},"source":{"system":"sec-edgar","filing":"0001209191-19-006627","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006627/doc4.xml","form_type":"4"}},{"id":3680380,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-02T01:24:12.000Z","date":"2019-01-30","kind":"exercise","acquired":false,"shares":19345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":96664,"derivative":{"exercise_price":23.85,"exercise_date":"2013-11-05","expiration_date":"2022-11-05","underlying":"Common Stock","underlying_shares":19345},"source":{"system":"sec-edgar","filing":"0001209191-19-006627","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006627/doc4.xml","form_type":"4"}},{"id":3680379,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-02T01:24:12.000Z","date":"2019-01-30","kind":"exercise","acquired":false,"shares":17860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":0,"derivative":{"exercise_price":13.9,"exercise_date":"2016-02-27","expiration_date":"2025-02-27","underlying":"Common Stock","underlying_shares":17860},"source":{"system":"sec-edgar","filing":"0001209191-19-006627","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006627/doc4.xml","form_type":"4"}},{"id":3680378,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-02T01:24:12.000Z","date":"2019-01-30","kind":"exercise","acquired":false,"shares":1128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":6771,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":1128},"source":{"system":"sec-edgar","filing":"0001209191-19-006627","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006627/doc4.xml","form_type":"4"}},{"id":3680377,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-02T01:24:12.000Z","date":"2019-01-30","kind":"exercise","acquired":false,"shares":5469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":7404,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":5469},"source":{"system":"sec-edgar","filing":"0001209191-19-006627","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006627/doc4.xml","form_type":"4"}},{"id":3680376,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-02-02T01:24:12.000Z","date":"2019-01-31","kind":"sale","acquired":false,"shares":21198,"price":130.72,"value":2771002.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":8649,"source":{"system":"sec-edgar","filing":"0001209191-19-006627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006627/doc4.xml","form_type":"4"}},{"id":3680375,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-02-02T01:24:12.000Z","date":"2019-01-31","kind":"exercise","acquired":true,"shares":21198,"price":23.85,"value":505572.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":29847,"source":{"system":"sec-edgar","filing":"0001209191-19-006627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006627/doc4.xml","form_type":"4"}},{"id":3680374,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-02-02T01:24:12.000Z","date":"2019-01-30","kind":"sale","acquired":false,"shares":43802,"price":130,"value":5694260.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":8649,"source":{"system":"sec-edgar","filing":"0001209191-19-006627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006627/doc4.xml","form_type":"4"}},{"id":3680373,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-02-02T01:24:12.000Z","date":"2019-01-30","kind":"exercise","acquired":true,"shares":19345,"price":23.85,"value":461378.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":52451,"source":{"system":"sec-edgar","filing":"0001209191-19-006627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006627/doc4.xml","form_type":"4"}},{"id":3680372,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-02-02T01:24:12.000Z","date":"2019-01-30","kind":"exercise","acquired":true,"shares":17860,"price":13.9,"value":248254.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":33106,"source":{"system":"sec-edgar","filing":"0001209191-19-006627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006627/doc4.xml","form_type":"4"}},{"id":3680371,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-02-02T01:24:12.000Z","date":"2019-01-30","kind":"exercise","acquired":true,"shares":1128,"price":13.71,"value":15464.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":15246,"source":{"system":"sec-edgar","filing":"0001209191-19-006627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006627/doc4.xml","form_type":"4"}},{"id":3680370,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2019-02-02T01:24:12.000Z","date":"2019-01-30","kind":"exercise","acquired":true,"shares":5469,"price":13.71,"value":74979.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":14118,"source":{"system":"sec-edgar","filing":"0001209191-19-006627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119006627/doc4.xml","form_type":"4"}},{"id":3782612,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock Option (right to buy)","published_at":"2018-10-26T22:43:58.000Z","date":"2018-10-24","kind":"exercise","acquired":false,"shares":11718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests based on time criteria (25% of the total option on 2/29/2017 and 1/48th of the total option in equal monthly installments thereafter)."}],"balance_after":12873,"derivative":{"exercise_price":13.71,"expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":11718},"source":{"system":"sec-edgar","filing":"0001209191-18-056332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056332/doc4.xml","form_type":"4"}},{"id":3782611,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock Option (right to buy)","published_at":"2018-10-26T22:43:58.000Z","date":"2018-10-24","kind":"exercise","acquired":false,"shares":29080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Half of the total options granted began vesting when the FDA provided marketing approval for eteplirsen on 9/19/2016 and the other half of the total options granted began vesting when Sarepta Therapeutics, Inc. filed a Marketing Authorization Application with the European Medicines Agency on 11/30/2016.  Vesting of the options allocated to the achievement of each goal is as follows: (i)  50% of the options allocated to the achieved goal vested immediately upon achievement of the performance condition (25% of the total performance-based options granted) and (ii) the remaining 50% of the options allocated to the achieved goal (25% of the total performance-based options granted) vest over four years.  25% of the remaining options vested on the first year anniversary of the grant date, or 2/28/2017 and 1/48th of the remaining options vests monthly thereafter."}],"balance_after":7899,"derivative":{"exercise_price":13.71,"expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":29080},"source":{"system":"sec-edgar","filing":"0001209191-18-056332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056332/doc4.xml","form_type":"4"}},{"id":3782610,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock Option (right to buy)","published_at":"2018-10-26T22:43:58.000Z","date":"2018-10-24","kind":"exercise","acquired":false,"shares":39006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests based on time criteria (25% of the total option on 2/27/2016 and 1/48th of the total option in equal monthly installments thereafter)."}],"balance_after":17860,"derivative":{"exercise_price":13.9,"expiration_date":"2025-02-27","underlying":"Common Stock","underlying_shares":39006},"source":{"system":"sec-edgar","filing":"0001209191-18-056332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056332/doc4.xml","form_type":"4"}},{"id":3782609,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock Option (right to buy)","published_at":"2018-10-26T22:43:58.000Z","date":"2018-10-24","kind":"exercise","acquired":false,"shares":9596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option to purchase shares is fully vested."}],"balance_after":116009,"derivative":{"exercise_price":23.85,"expiration_date":"2022-11-05","underlying":"Common Stock","underlying_shares":9596},"source":{"system":"sec-edgar","filing":"0001209191-18-056332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056332/doc4.xml","form_type":"4"}},{"id":3782608,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2018-10-26T22:43:58.000Z","date":"2018-10-24","kind":"gift","acquired":true,"shares":12012,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By wife"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved a gift of securities by the reporting person to his wife."}],"balance_after":12012,"source":{"system":"sec-edgar","filing":"0001209191-18-056332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056332/doc4.xml","form_type":"4"}},{"id":3782607,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2018-10-26T22:43:58.000Z","date":"2018-10-24","kind":"gift","acquired":false,"shares":12012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved a gift of securities by the reporting person to his wife."}],"balance_after":8649,"source":{"system":"sec-edgar","filing":"0001209191-18-056332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056332/doc4.xml","form_type":"4"}},{"id":3782606,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2018-10-26T22:43:58.000Z","date":"2018-10-24","kind":"sale","acquired":false,"shares":107524,"price":127.74,"value":13735115.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $120.87 to $134.39, inclusive.  The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth herein."}],"balance_after":20661,"source":{"system":"sec-edgar","filing":"0001209191-18-056332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056332/doc4.xml","form_type":"4"}},{"id":3782605,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2018-10-26T22:43:58.000Z","date":"2018-10-24","kind":"exercise","acquired":true,"shares":11718,"price":13.71,"value":160653.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":128185,"source":{"system":"sec-edgar","filing":"0001209191-18-056332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056332/doc4.xml","form_type":"4"}},{"id":3782604,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2018-10-26T22:43:58.000Z","date":"2018-10-24","kind":"exercise","acquired":true,"shares":29080,"price":13.71,"value":398686.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":116467,"source":{"system":"sec-edgar","filing":"0001209191-18-056332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056332/doc4.xml","form_type":"4"}},{"id":3782603,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2018-10-26T22:43:58.000Z","date":"2018-10-24","kind":"exercise","acquired":true,"shares":39006,"price":13.9,"value":542183.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":87387,"source":{"system":"sec-edgar","filing":"0001209191-18-056332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056332/doc4.xml","form_type":"4"}},{"id":3782602,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2018-10-26T22:43:58.000Z","date":"2018-10-24","kind":"exercise","acquired":true,"shares":9596,"price":23.85,"value":228864.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":48381,"source":{"system":"sec-edgar","filing":"0001209191-18-056332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056332/doc4.xml","form_type":"4"}},{"id":3850110,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2018-08-08T22:14:14.000Z","date":"2018-08-08","kind":"tax_withholding","acquired":false,"shares":8501,"price":121.02,"value":1028791.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of performance-based restricted stock award granted on September 19, 2016."}],"balance_after":38785,"source":{"system":"sec-edgar","filing":"0001209191-18-045903","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118045903/doc4.xml","form_type":"4"}},{"id":3886004,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-06-21T16:16:30.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":12500,"derivative":{"exercise_price":28.14,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-18-038938","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919118038938/doc4.xml","form_type":"4"}},{"id":3899569,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2018-06-08T22:45:16.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":18400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":18400,"derivative":{"exercise_price":10.28,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":18400},"source":{"system":"sec-edgar","filing":"0001140361-18-027929","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511034/000114036118027929/doc1.xml","form_type":"4"}},{"id":3919472,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Restricted Stock Units","published_at":"2018-05-24T22:05:45.000Z","date":"2018-05-22","kind":"exercise","acquired":false,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 10, 2017, the reporting person was granted restricted stock units that vest based on the Company's satisfaction of certain performance criteria. The first performance criterion was met on August 3, 2017, resulting in vesting of 50% of such restricted stock units, and the second performance criterion was met on May 22, 2018, resulting in vesting of 25% of such restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 10, 2017, the reporting person was granted restricted stock units that vest based on the Company's satisfaction of certain performance criteria. The first performance criterion was met on August 3, 2017, resulting in vesting of 50% of such restricted stock units, and the second performance criterion was met on May 22, 2018, resulting in vesting of 25% of such restricted stock units."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6649},"source":{"system":"sec-edgar","filing":"0001209191-18-033111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118033111/doc4.xml","form_type":"4"}},{"id":3919471,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2018-05-24T22:05:45.000Z","date":"2018-05-22","kind":"tax_withholding","acquired":false,"shares":2024,"price":89.22,"value":180581.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of restricted stock units granted on March 10, 2017."}],"balance_after":47286,"source":{"system":"sec-edgar","filing":"0001209191-18-033111","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118033111/doc4.xml","form_type":"4"}},{"id":3919470,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2018-05-24T22:05:45.000Z","date":"2018-05-22","kind":"exercise","acquired":true,"shares":6649,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":49310,"source":{"system":"sec-edgar","filing":"0001209191-18-033111","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118033111/doc4.xml","form_type":"4"}},{"id":3993673,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2018-03-16T22:08:20.000Z","date":"2018-03-15","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11768,"derivative":{"exercise_price":23.85,"exercise_date":"2013-11-05","expiration_date":"2022-11-05","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-18-020347","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118020347/doc4.xml","form_type":"4"}},{"id":3993672,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2018-03-16T22:08:20.000Z","date":"2018-03-15","kind":"tax_withholding","acquired":false,"shares":734,"price":81.22,"value":59615.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person delivered already-owned shares of Common Stock in payment of the option exercise price. Such an \"option swap\" enables the exercise and holding of shares of Common Stock by the Reporting Person."}],"balance_after":42661,"source":{"system":"sec-edgar","filing":"0001209191-18-020347","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118020347/doc4.xml","form_type":"4"}},{"id":3993671,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2018-03-16T22:08:20.000Z","date":"2018-03-15","kind":"exercise","acquired":true,"shares":2500,"price":23.85,"value":59625.0,"ownership":{"direct":true},"balance_after":43395,"source":{"system":"sec-edgar","filing":"0001209191-18-020347","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118020347/doc4.xml","form_type":"4"}},{"id":4009164,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock option (right to buy)","published_at":"2018-03-07T23:04:53.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":97500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant."}],"balance_after":97500,"derivative":{"exercise_price":71.45,"expiration_date":"2028-03-05","underlying":"Common Stock","underlying_shares":97500},"source":{"system":"sec-edgar","filing":"0001209191-18-017792","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118017792/doc4.xml","form_type":"4"}},{"id":4141497,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2017-12-06T02:03:17.000Z","date":"2017-12-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on January 1, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":30000,"derivative":{"exercise_price":4.73,"expiration_date":"2027-11-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-17-045125","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1511034/000114036117045125/doc1.xml","form_type":"4"}},{"id":4241815,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Restricted Stock Units","published_at":"2017-08-07T20:42:05.000Z","date":"2017-08-03","kind":"exercise","acquired":false,"shares":13298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 3, 2017, the reporting person was granted restricted stock units that vest based on the Company's satisfaction of certain performance criteria. The first performance criterion was met on August 3, 2017, resulting in vesting of 50% of such restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 3, 2017, the reporting person was granted restricted stock units that vest based on the Company's satisfaction of certain performance criteria. The first performance criterion was met on August 3, 2017, resulting in vesting of 50% of such restricted stock units."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13298},"source":{"system":"sec-edgar","filing":"0001209191-17-047901","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919117047901/doc4.xml","form_type":"4"}}],"next_cursor":"2017-08-07T20:42:05.000000Z,4241815"}